ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma

Zhang, Sibin; Xiao, Xu; Wang, Yu; Song, Tianjun; Li, Chenlong; Bao, Hongbo; Liu, Qing; Sun, Guiyin; Sun, Xiaoyang; Su, Tianqi; Fu, Tianjiao; Wang, Yujie; Liang, Peng*哈尔滨医科大学
Frontiers in Genetics2022-6-2DOI: 10.3389/fgene.2022.899125
2被引10阅读
引用收藏
分享

摘要

Background: Glioma is one of the most aggressive cancer types affecting the central nerve system, with poor overall survival (OS) rates. The present study aimed to construct a novel immune-related signature to predict prognosis and the efficiency of immunotherapy in patients with glioma.Methods: The mRNA expression data and other clinical information of patients with glioblastoma multiforme (GBM) and low grade glioma (LGG) were obtained from The Cancer Genome Atlas and Chinese Glioma Genome Atlas databases. The immune-related genes were obtained from the Immunology Database and Analysis Portal database. Subsequently, an immune-related signature was created following the results obtained from the Least Absolute Shrinkage and Selection Operator regression model. To validate the predictability of the signature, Kaplan-Meier survival curves and time-dependent receiver operating characteristic curves were created. Moreover, both univariate and multivariate analyses were carried out using the OS between this signature and other clinicopathologic factors, and a nomogram was constructed. In addition, the association between signature, immune cell infiltration, tumor mutation burden and immunophenoscore were determined.Results: Results of the present study using 118 GBM and LGG samples uncovered 15 immune-related genes that were also differently expressed in glioma samples. These were subsequently used to construct the immune-related signature. This signature exhibits the ability to predict prognosis, the infiltration of immune cells in the tumor microenvironment and the response of patients with glioma to immunotherapy.Conclusion: Results of the present study demonstrated that the aforementioned novel immune-related signature may accurately predict prognosis and the response of patients with glioma to immunotherapy.

学科与关键词

关键词
gliomabioinformatics signatureprognosisimmune microenvironmentimmunotherapy
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2022-06-02
卷期
第 13 卷
页码
899125
DOI
10.3389/fgene.2022.899125
期刊等级
3区
成果收录
SCIE

作者

  • Z

    Zhang, Sibin (第一作者)

    harbin med univ

  • X

    Xiao, Xu

    harbin med univ

查看全部 13 位作者收起作者
  • W

    Wang, Yu

  • S

    Song, Tianjun

    2

  • L

    Li, Chenlong

    harbin med univ

  • B

    Bao, Hongbo

    harbin med univ

  • L

    Liu, Qing

    harbin med univ

  • S

    Sun, Guiyin

    harbin med univ

  • S

    Sun, Xiaoyang

    harbin med univ

  • S

    Su, Tianqi

    harbin med univ

  • F

    Fu, Tianjiao

    harbin med univ

  • W

    Wang, Yujie

  • L

    Liang, Peng (通讯)

    harbin med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417